Short answer
There is no reliable published average profit margin for med spas; what AmSpa's 2024 industry report does publish is average revenue of $1,398,833 per location, 245 visits a month and $527 per visit. Your own margin only means something when package revenue is recognized on delivery, injectables are costed as used and the owner is paid a market salary in the P&L. In a well-built med spa P&L we aim for 40% to 50% gross margin on injectables after product and provider cost, 60% to 70% on energy devices, rent under 10% of revenue and EBITDA of 15% to 20% after normalized owner compensation; those are the firm's practice targets, not industry statistics.
Key takeaways
- AmSpa's 2024 report recap gives the only solid public numbers: 10,488 locations in 2023, average revenue $1,398,833, 245 visits per month, $527 per visit, 73% repeat patients and 81% single-location practices averaging 8 employees; it does not publish a profit margin.
- Published margin claims are incomparable because of sample selection, cash versus accrual timing, how owner compensation is treated and where provider pay is classified.
- A usable med spa P&L reports revenue by service line, puts product cost, treating-provider cost and consumables in cost of goods sold, carries a normalized owner salary, and is managed to EBITDA after owner pay.
- The targets we use, labeled as the firm's own and not industry data: injectable product cost 30% to 38% of injectable revenue, provider cost 24% to 30% of service revenue, injectable gross margin 40% to 50%, device gross margin 60% to 70%, rent under 10%, EBITDA 15% to 20% after owner pay.
- In an illustrative month, booking packages when sold, expensing product when purchased and leaving owner draws out of the P&L turned a true 9.6% margin into an apparent 26.4%.
- Your best benchmark is your own practice: the same KPI sheet by location, by provider and on a trailing-three-month basis.
In this guide
Every med spa owner eventually asks what her margin should be, and the internet answers with a confident percentage that nobody can trace. The problem is not that the number is wrong; it is that no one knows what it measures. Before or after the owner pays herself? With packages counted when sold or when delivered? With product expensed when the order arrives or when the syringe is used? Change those three choices and the same practice swings from a 26% margin to under 10%.
This guide separates what is published and reliable from what is not, lays out the profit and loss structure that makes a margin mean something, and gives the targets we use when we review a med spa P&L, labeled as exactly that.
What is known about med spa economics
The best public data comes from AmSpa's 2024 Medical Spa State of the Industry report recap. It covers size, volume and ticket, not profit.
| Measure (AmSpa 2024 report recap) | Figure |
|---|---|
| U.S. med spa locations | 10,488 in 2023, up from 8,899 in 2022 |
| Average annual revenue per med spa | $1,398,833, up from $1,307,587 in the prior report |
| Average patient visits per month | 245 |
| Average spend per visit | $527 |
| Repeat patients | 73% of patients |
| Single-location practices | 81% of med spas, averaging 8 employees |
AmSpa's statistics page estimates industry revenue at more than $17 billion, growing by more than $1 billion a year. Note what is absent: no average profit margin appears in the free recap, and we do not quote one.
Why published "average margin" claims are unreliable
Four things make a margin figure from one practice incomparable with another's. The sample: survey respondents are self-selected and tend to be practices doing well enough to answer. The accounting method: a cash-basis P&L books package money as revenue the day it is collected, so a practice in a growth phase looks far more profitable than it is. Owner compensation: most single-owner med spas are run by the person who also injects, and if she takes distributions instead of a salary, her labor is free in the P&L and the "margin" includes her wages. And classification: one practice puts injector pay in cost of goods sold, another in payroll, a third pays a medical director and management fee that a solo-physician practice never sees.
So the useful question is not "what is the industry margin" but "what is my margin when my books are built correctly, and how does it move month to month." That requires a specific P&L structure.
The P&L structure that makes margins real
Revenue is reported by service line: injectables (neurotoxin and filler), energy devices (laser, RF, body contouring), skincare services and facials, retail product, and a small line for membership fees and forfeitures. Package and membership money is recognized into the service lines as treatments are delivered, not when the card is charged; the memberships, packages and gift cards guide covers the liability side.
Cost of goods sold carries three things that vary with each treatment: product cost (the syringe or vial used, relieved from inventory, not the month's purchases), treating-provider cost (wages, commissions and employer payroll taxes of the people who perform treatments) and consumables (tips, gel, numbing cream, retail product cost). Gross margin is then meaningful by line. Operating expenses hold everything else: administrative payroll, rent, marketing, merchant fees, software, insurance, the medical director, and a normalized owner salary, which is a market wage for the work the owner does whether or not she takes it. Below that sit depreciation and interest. The number we manage to is EBITDA after normalized owner compensation. If you are unsure how to read the layers, start with how to read a profit and loss statement.
The targets we use
These are the firm's practice targets, built from the economics of each service line when the books are kept correctly. They are not industry statistics and no survey stands behind them. A practice outside a range is not failing; it has a question to answer.
| Measure | What we aim for |
|---|---|
| Injectable product cost as a share of injectable revenue | 30% to 38%; above 40% we look at pricing, discounting and waste |
| Treating-provider cost as a share of service revenue | 24% to 30%, including commissions and employer taxes |
| Gross margin on injectables, after product and provider cost | 40% to 50% |
| Gross margin on energy devices, after consumables and provider cost | 60% to 70%, with device cost in depreciation |
| Gross margin on retail | 40% to 50% |
| Rent and occupancy as a share of revenue | Under 10% |
| Marketing as a share of revenue | 5% to 8% once the practice is established |
| All labor including normalized owner pay | Under 45% of revenue |
| EBITDA after normalized owner compensation | 15% to 20% for a mature single location |
Two comments on using them. Injectable margin is structurally thinner than device margin because the product is expensive and the manufacturer, not you, sets its cost; a practice that is 70% injectables will show a lower blended gross margin than a device-heavy practice at the same quality of management, which is why we look by line. And rent under 10% is easier at $1.4 million of revenue than at $600,000, so a young practice should read that line as a destination.
Three distortions, and what the same practice looks like without them
Three bookkeeping habits account for most of the gap between the margin an owner believes and the margin she has. Packages and memberships are booked as revenue when sold, which borrows next quarter's revenue to flatter this month. Injectables are expensed when purchased, so cost follows the ordering pattern rather than the treatment pattern; a month with a big order looks terrible and the next month looks wonderful. And the owner's draws never appear in the P&L, so her clinical and management labor costs nothing.
Here is one illustrative month for a single-location practice, first as the owner's bookkeeper had it and then after the three corrections. Earned revenue is lower because $18,000 of new package sales came out and $12,000 of redemptions from earlier sales came in; product cost is higher because $21,000 of product was used although only $15,000 was purchased; and a $9,000 market salary for the owner's work is added.
| October (illustrative) | Before | After |
|---|---|---|
| Revenue | $121,000 (cash collected) | $115,000 (earned) |
| Injectable product cost | ($15,000) purchased | ($21,000) used |
| Provider cost | ($27,000) | ($27,000) |
| Consumables and retail cost | ($7,000) | ($7,000) |
| Operating expenses | ($35,000) | ($35,000) |
| Owner compensation, normalized | — | ($9,000) |
| Depreciation | ($5,000) | ($5,000) |
| Net income | $32,000 | $11,000 |
| Margin | 26.4% | 9.6% |
Nothing about the practice changed. The 26% was never there; it was $6,000 of other people's treatments, $6,000 of inventory drawdown and $9,000 of unpaid labor. The 9.6% is the number to manage, and it is below our target, which is the point of finding out. The inventory mechanics are in med spa inventory accounting.
A worked example: a healthy P&L at the AmSpa average
Take an illustrative single-location practice with $1,400,000 of annual revenue, close to the AmSpa average, with the books built as described and results inside our targets. Revenue: injectables $784,000, energy devices $294,000, skincare services $140,000, retail $112,000, membership fees and forfeitures $70,000. Cost of goods sold: injectable product at 33% of injectable revenue ($258,720), treating-provider cost at 25% of service revenue ($304,500), device consumables $23,520, skincare supplies $14,000 and retail product cost $61,600, for $662,340 in total.
Gross margin is $737,660, or 52.7%, and by line it is 42% on injectables, 67% on devices, 65% on skincare services and 45% on retail. Operating expenses are $532,000: administrative payroll $105,000, a normalized owner salary of $110,000, rent $98,000 (7.0%), marketing $77,000 (5.5%), merchant fees $42,000, the medical director $30,000, and software, insurance, supplies and professional fees $70,000. EBITDA after owner pay is $205,660, or 14.7%, and after $60,000 of depreciation and $15,000 of interest, pre-tax income is $130,660. That is a practice paying its owner a market wage and still keeping about $0.15 of every dollar before financing; it is what a correctly built set of books should show, and show truthfully.
The monthly KPI set and benchmarking your own locations
A margin is a result; the KPIs are the levers. Each month we track earned revenue against cash collected, revenue per visit (the AmSpa average is $527), visits per provider day, product cost as a share of injectable revenue, provider cost as a share of service revenue, gross margin by line, the deferred revenue balance and its change, repeat-patient share (AmSpa reports 73%), and EBITDA after owner pay. The full list with formulas is in 15 med spa KPIs every owner should review monthly.
Your most reliable benchmark is yourself. A multi-location practice should run the same chart of accounts in every location, record rent, payroll and product by location, and compare the KPI sheet across locations on a trailing-three-month basis; a location whose product cost runs eight points above its sibling has a pricing, waste or counting problem that no industry average would have revealed. The 81% of practices with one location can do the same by provider and by month, comparing this October with the trailing twelve and with the targets above.
Common mistakes
Comparing a cash-basis margin with someone else's accrual-basis margin. Treating the owner's distributions as profit and her labor as free. Booking package sales as revenue and then wondering why a slow redemption month shows a loss. Blending injectables and devices into one gross margin and concluding the practice is fine. Reading a single month instead of a trailing three. Chasing a margin by cutting marketing, which lowers next quarter's visits. And accepting any benchmark whose definition of revenue, cost and owner pay you cannot state.
When to get help
If you cannot say what your gross margin on injectables was last month, after product and provider cost and with packages recognized on delivery, the books are not yet built to answer the margin question, and no benchmark will help until they are. That rebuild is usually a fixed-fee cleanup project followed by a monthly close that produces the P&L by line and the KPI sheet.
Balance Partners is a CPA-led accounting practice in Tampa working with medical aesthetics practices nationwide. Our med spa accounting and tax services and monthly bookkeeping and accounting pages describe the engagement; request a 20-minute fit call and bring your last P&L, and we will tell you which of the three distortions it carries.
Want this handled for your business, not just explained?
Request a 20-Minute Fit Call → Med Spa Accounting & Tax Services →Frequently asked questions
What is the average profit margin for a med spa?
No reliable published figure exists; AmSpa's free 2024 report recap gives average revenue ($1,398,833), visits (245 a month) and spend per visit ($527) but no margin. Percentages quoted online rarely say whether the owner was paid, whether packages were counted when sold or delivered, or whether product was expensed when bought or used, and those three choices can move the result by fifteen points or more, as the illustration in this guide shows. Build your own P&L correctly and manage to that number.
What gross margin should I expect on injectables versus lasers?
In a well-built med spa P&L we aim for 40% to 50% on injectables after product and provider cost, and 60% to 70% on energy devices after consumables and provider cost, with the device itself in depreciation. Injectables are thinner because the manufacturer sets the product cost. These are the firm's targets not industry statistics.
Should I count my own pay when calculating my med spa's margin?
Yes. Put a market salary for the work you actually do, clinical and managerial, into operating expenses whether or not you draw it, and measure EBITDA after that salary. Otherwise the margin includes your unpaid labor, overstates the business's value and makes comparison with any other practice impossible.
Why does my margin swing so much from month to month?
Usually because package and membership sales are booked as revenue when collected and injectables are expensed when ordered, so the P&L follows your sales promotions and your ordering calendar rather than your treatments. Recognize package revenue on delivery, relieve product from inventory as used and the swings mostly disappear; what remains is real seasonality.
How do I benchmark my locations against each other?
Run the same chart of accounts in every location, record rent, payroll and product by location, and compare one KPI sheet across them on a trailing-three-month basis: revenue per visit, product cost as a share of injectable revenue, provider cost as a share of service revenue, gross margin by line, deferred revenue balance and EBITDA after owner pay. A gap between your own locations is more actionable than any industry average.
Founder of Balance Partners. Florida-licensed CPA and IRS Enrolled Agent with more than a decade of accounting and tax experience. Jenny writes and reviews every guide on this site. About Jenny
Sources
Related guides
This article is general educational information for U.S. business owners and is not accounting, tax, legal, payroll or financial advice for your situation. Rules change and vary by entity, state and facts. Balance Partners, LLC does not provide audit, review or other attest services. Last reviewed October 15, 2026.